| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| GC34224-10mg |
|
— |
AMARA peptide TFA - Glpbio |
0 | 需詢價(jià) | C64H116F3N27O18S | |
| GC34224-5mg |
|
— |
AMARA peptide TFA - Glpbio |
0 | 需詢價(jià) | C64H116F3N27O18S | |
| GC34224-1mg |
|
— |
AMARA peptide TFA - Glpbio |
0 | 需詢價(jià) | C64H116F3N27O18S | |
| GC34223-10mg |
|
— |
Dermorphin Analog - Glpbio |
0 | 需詢價(jià) | C44H59N11O10 | |
| GC34223-5mg |
|
— |
Dermorphin Analog - Glpbio |
0 | 需詢價(jià) | C44H59N11O10 | |
| GC34223-1mg |
|
— |
Dermorphin Analog - Glpbio |
0 | 需詢價(jià) | C44H59N11O10 | |
| GC34222-5mg |
|
— |
Galanin (1-16), mouse, porcine, rat TFA - Glpbio |
0 | 需詢價(jià) | C80H117F3N20O23 | |
| GC34222-1mg |
|
— |
Galanin (1-16), mouse, porcine, rat TFA - Glpbio |
0 | 需詢價(jià) | C80H117F3N20O23 | |
| GC34222-500μg |
|
— |
Galanin (1-16), mouse, porcine, rat TFA - Glpbio |
0 | 需詢價(jià) | C80H117F3N20O23 | |
| GC34221-10mg |
|
— |
GroES mobile loop - Glpbio |
0 | 需詢價(jià) | C51H90N14O20 | |
| GC34221-5mg |
|
— |
GroES mobile loop - Glpbio |
0 | 需詢價(jià) | C51H90N14O20 | |
| GC34221-1mg |
|
— |
GroES mobile loop - Glpbio |
0 | 需詢價(jià) | C51H90N14O20 | |
| GC34219-1mg |
|
— |
ATWLPPR Peptide TFA - Glpbio |
0 | 需詢價(jià) | C42H62F3N11O11 | |
| GC34219-10mM(1mLinDMSO) |
|
— |
ATWLPPR Peptide TFA - Glpbio |
0 | 需詢價(jià) | C42H62F3N11O11 | |
| GC34218-10mg |
|
946414-94-4 |
Nivolumab (BMS-936558) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34218-1mg |
|
946414-94-4 |
Nivolumab (BMS-936558) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34217-5mg |
|
205923-56-4 |
Cetuximab (C225) - Glpbio |
0 | 需詢價(jià) | C6484H10042N1732O2023S36 | |
| GC34217-1mg |
|
205923-56-4 |
Cetuximab (C225) - Glpbio |
0 | 需詢價(jià) | C6484H10042N1732O2023S36 | |
| GC34216-5mg |
|
216974-75-3 |
Bevacizumab (Anti-Human VEGF, Humanized Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34215-25mg |
|
180288-69-1 |
Trastuzumab (Anti-Human HER2, Humanized Antibody) - Glpbio |
0 | 需詢價(jià) | C6470H10012N1726O2013S42 | |
小泰
|
010-60710855
|